Q2 FY26 record results; ATH rally; price hikes implemented; stock drop; foldable production boost with bearish counterpoint; iPhone Ultra intentional supply strategy; China sales drop
Key Questions
What were Apple's Q2 FY26 financial results?
Apple reported record Q2 results amid an all-time high stock rally. The company implemented broad price hikes across products due to ongoing memory chip shortages.
Why did Apple's stock drop after its recent high?
The stock fell about 6% on June 25 to around $275, breaking below its IBD buy zone. Contributing factors included price hike concerns and broader market weakness.
What is Apple's plan for foldable iPhone production?
Apple has boosted planned foldable iPhone output to 10 million units for H2 2026, up from an initial 7-8 million target. The device is expected to launch in September alongside iPhone 18 Pro models.
What risks does analyst Ming-Chi Kuo highlight for the foldable iPhone?
Kuo warned of potential supply chain issues that could jeopardize the September launch window. This has introduced near-term risk to the bullish production narrative.
Why is Apple limiting iPhone Ultra supply at launch?
The limited supply strategy is viewed as intentional to reinforce Apple's premium brand positioning and pricing power. It aligns with the company's historical approach to high-end product launches.
How did Apple's sales perform in China during the 618 festival?
Sales fell 9% year-over-year despite steep discounts, though Apple regained the No. 2 market position. Broader market conditions and competition from Huawei contributed to the weakness.
What are key analyst price targets for Apple stock?
Morningstar raised its fair value estimate to $290, while 24/7 Wall St. set a $336.98 target with a longer-term $400 view. Technical analysis points to support levels at $252-$236.
What does the UBS survey reveal about consumer sentiment for iPhones?
US purchase intent has risen while China intent has declined, with overall interest in AI features showing signs of fading. This mixed data adds nuance to growth expectations.
Q2 record results. Stock ATH $317. Apple implemented broad price hikes due to memory shortage. Stock dropped ~6% on June 25 to ~$275, breaking below IBD buy zone. Technical analysis targets $252-$236. Morningstar raised fair value to $290. Polymarket odds of iPhone 18 Pro >$1,100 up to 90%. Stock partially recovered on foldable news. UBS survey data adds mixed consumer sentiment: US iPhone intent up, China down, AI feature interest fading. New positive catalyst: Foldable iPhone production boost confirmed by Nikkei; Apple targeting 10M units (up ~30% from initial 7-8M), total H2 2026 iPhone orders 85M. Launch alongside iPhone 18 Pro/Pro Max in September, iPhone 18 delayed to March 2027. Stock up 4% on this news, partially reversing the June 25 drop. 24/7 Wall St. adds $336.98 price target and $400 long-term view, reinforcing bullish foldable thesis. New bearish counterpoint: Kuo warns of foldable iPhone supply issues that could blow September launch window; premarket dip noted. This adds risk to the bullish narrative. New nuance: iPhone Ultra launch strategy article argues limited supply is intentional, reinforcing Apple's premium brand playbook and pricing power. This provides a bullish counterpoint to Kuo's bearish supply warnings. Recent articles confirm 2027 iPad Pro and MacBook Pro refresh timeline, adding to product cycle narrative. New negative data: Apple's China 618 sales fell 9% YoY despite steep discounts, regaining #2 but at cost of pricing. Broader market down 13%, Huawei up. Counterpoint sees further weakness H2 2026. This challenges bullish China recovery narrative and adds to margin pressure from memory costs.